Kristen Sanders Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20 Michelle Dr, Hunlock Creek, PA 18621 Phone: 570-262-6850 |
Jennifer Ann Kennedy, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20 Michelle Dr, Hunlock Creek, PA 18621 Phone: 570-262-6850 |
Mrs. Nancy Marie Arant-jacobs, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20 Michelle Dr, Hunlock Creek, PA 18621 Phone: 570-262-4962 |
Jennifer Kelley, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2449 State Route 118 Ste 2, Hunlock Creek, PA 18621 Phone: 570-690-4908 |
Gerald Joseph Gostynski Jr. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20 Michelle Dr, Hunlock Creek, PA 18621 Phone: 570-262-6850 Fax: 570-477-3604 |
News Archive
The United States faces a converging public health crisis as the nation's opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.
Sun Pharmaceutical Industries Ltd. today announced that PROXY Governance, Inc., a leading independent proxy advisory firm, recommended that shareholders of Taro Pharmaceutical Industries Ltd. withhold their votes for the re-election of the existing board of directors of Taro and vote against the board's two nominees for external director and against both of the board's indemnification proposals in the upcoming Annual General Meeting of Taro's shareholders scheduled for December 31, 2009.
A national survey released today by The Ohio State University Wexner Medical Center shows that most women don't know the risks or symptoms females face when it comes to having a stroke.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, announces the receipt of notice on June 27, 2012 from the NYSE Amex LLC, that the NYSE-Amex has accepted the CorMedix's plan to regain compliance with continued listing standards of the NYSE-Amex.
› Verified 1 days ago